[Coagulation factors and hemostatic agents].
A large variety of therapeutic agents are available to prevent or treat hemorrhagic events. An etiologic focusing is essential to permit a rational use of these drugs. Some medications are cheap, others are very expensive, and the clinician has to evaluate the cost-effectiveness of his prescription in each situation.
Deneys
V
V
Laboratoire d'Hémostase, Cliniques Universitaires Saint-Luc. deneys@sang.ucl.ac.be
Hermans
C
C
D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001779:Blood Coagulation Factors / Q000502:physiology*; D003362:Cost-Benefit Analysis; D006470:Hemorrhage / Q000188:drug therapy; D006490:Hemostatics / Q000191:economics / Q000494:pharmacology*; D006801:Humans
D000933:Antifibrinolytic Agents; D001779:Blood Coagulation Factors; D006490:Hemostatics